Parallel Advisors’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Parallel Advisors’s Portfolio ZEAL Stock Details ZEAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-58	Closed	-$2K	–	3371
2021 Q2	$2K	Hold	58	–	–	﹤0.01%	2654
2021 Q1	$2K	Sell	58 -36	-38%	-$1.21K	﹤0.01%	2554
2020 Q4	$3K	Hold	94	–	–	﹤0.01%	2246
2020 Q3	$4K	Hold	94	–	–	﹤0.01%	2152
2020 Q2	$3K	Buy	94 +36	+62%	+$1.28K	﹤0.01%	2144
2020 Q1	$2K	Buy	+58	New	+$2.02K	﹤0.01%	2205

Other funds holding ZEAL

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JCM

Jacobi Capital Management Pittston, Pennsylvania $2.04B AUM 26.26% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Parallel Advisors's ZEAL Position: Q3 2021 in Review

Parallel Advisors sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q3 2021, closing a stake of 58 shares — an estimated $2K sold.

Parallel Advisors first reported a position in ZEAL in Q1 2020 and held it in 6 quarters. The position peaked at $4K in Q3 2020. 14 funds tracked by Wall St. Rank hold ZEAL as of Q3 2021.

Parallel Advisors reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q3 2021 after selling out during the quarter.
Parallel Advisors sold 58 Zealand Pharma A/S American Depositary Shares shares in Q3 2021, an estimated $2K.
Parallel Advisors first reported a position in Zealand Pharma A/S American Depositary Shares in Q1 2020 and held it in 6 quarters.
Parallel Advisors's Zealand Pharma A/S American Depositary Shares position peaked at $4K in Q3 2020.
14 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q3 2021.

Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.